Actuate Therapeutics, Inc. announced that data on their investigational drug elraglusib, designed to treat advanced salivary gland carcinoma by inhibiting glycogen synthase kinase-3 beta (GSK-3β ...

We were encouraged by the response rate among the non-Adenoid Cystic Carcinoma (ACC) population with nuclear GSK-3β overexpression given this difficult to treat and rare cancer type", said Dr ...

The type of prostate cancer tells you which type of cell the cancer started in. The most common type is adenocarcinoma of the prostate. Prostate cancer risk groups and the Cambridge Prognostic Group ...